{"count": 2, "results": [{"_id": "26032655", "pmid": 26032655, "pmcid": "PMC4506413", "title": "Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study", "journal": "J Ovarian Res", "authors": ["Jensterle M", "Salamun V", "Kocjan T", "Vrtacnik Bokal E", "Janez A"], "date": "2015-06-02T00:00:00Z", "doi": "10.1186/s13048-015-0161-3", "meta_date_publication": "2015 Jun 2", "meta_volume": "8", "meta_issue": "", "meta_pages": "32", "score": 50072.316, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment arm", "citations": {"NLM": "Jensterle M, Salamun V, Kocjan T, Vrtacnik Bokal E, Janez A. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study J Ovarian Res. 2015 Jun 2;8():32. PMID: 26032655", "BibTeX": "@article{26032655, title={Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study}, author={Jensterle M and Salamun V and Kocjan T and Vrtacnik Bokal E and Janez A}, journal={J Ovarian Res}, volume={8}, pages={32}}"}}, {"_id": "28233407", "pmid": 28233407, "title": "Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine.", "journal": "Int J Ment Health Nurs", "authors": ["Coates D", "Woodford P", "Higgins O", "Grover D"], "date": "2018-02-01T00:00:00Z", "doi": "10.1111/inm.12321", "meta_date_publication": "2018 Feb", "meta_volume": "27", "meta_issue": "1", "meta_pages": "303-310", "score": 50041.652, "text_hl": "At the first appointment, the majority of clients had @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ that was mostly left untreated; many of these clients were commenced on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. The outcomes are positive, and show that the majority of clients lost weight (82.5%) and had a @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@reduction@@@ in @DISEASE_MASS_syndrome @DISEASE_MESH:C536030 @@@body mass@@@ index (84.6%); nearly half (44.4%) had a @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@reduction@@@ in waist @<m>DISEASE_Abidi_X_linked_mental_retardation_syndrome</m> @DISEASE_MESH:C535556 @@@circumference@@@. ", "citations": {"NLM": "Coates D, Woodford P, Higgins O, Grover D. Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine. Int J Ment Health Nurs. 2018 Feb;27(1):303-310. PMID: 28233407", "BibTeX": "@article{28233407, title={Evaluation of a general practitioner-led cardiometabolic clinic: Physical health profile and treatment outcomes for clients on clozapine.}, author={Coates D and Woodford P and Higgins O and Grover D}, journal={Int J Ment Health Nurs}, volume={27}, number={1}, pages={303-310}}"}}]}